Ran has been with OrbiMed since 2021 and is a Director on the Asia team. Prior to joining OrbiMed, Ran was Vice President in biotech venture investments at Matrix Partners, China. Previously, Ran was a consultant at ZS Associates supporting Roche/Genentech, Gilead, and Novartis with M&A and clinical development strategies. Ran holds a B.A. in Computational Biology from the University of Pennsylvania and a B.S.E in Operations Management from Wharton Business School, Roy Vagelos Life Science Management Program, where she was also a certified Emergency Medical Technician. Ran was selected for the Forbes 30 Under 30 list.
Ask Me About:
- My LiDAR map of the next big drug and the next-gen entrepreneurs
- Applying fundamental models in biotech and healthcare (programmers and physicists are welcome)
- Cocktail recipes and karaoke